av/takeda--big.svg

NYSE:TAK

Takeda Pharmaceutical Company Limited

  • Stock

USD

Last Close

4,239.00

26/07 06:15

Market Cap

6.77T

Beta: 0.68

Volume Today

3.12M

Avg: 2.34M

PE Ratio

18.10

PFCF: −50.39

Dividend Yield

0.01%

Payout:161.87%

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
revenue
1.69T
-
1.78T
5.09%
1.81T
1.66%
1.73T
4.17%
1.77T
2.22%
2.10T
18.45%
3.29T
56.93%
3.20T
2.84%
3.57T
11.61%
4.03T
12.85%
4.26T
5.87%
cost of revenue
490.26B
-
520.99B
6.27%
535.40B
2.77%
558.75B
4.36%
495.92B
11.25%
659.69B
33.02%
1.09T
65.19%
994.31B
8.76%
1.11T
11.32%
1.24T
12.40%
2.08T
67.10%
gross profit
1.20T
-
1.26T
4.61%
1.27T
1.20%
1.17T
7.76%
1.27T
8.63%
1.44T
12.78%
2.20T
53.14%
2.20T
0.09%
2.46T
11.74%
2.78T
13.05%
2.18T
21.50%
selling and marketing expenses
general and administrative expenses
selling general and administrative expenses
556.21B
-
612.61B
10.14%
650.77B
6.23%
619.06B
4.87%
628.11B
1.46%
717.60B
14.25%
964.74B
34.44%
875.66B
9.23%
886.36B
1.22%
997.31B
12.52%
1.05T
5.67%
research and development expenses
341.56B
-
382.10B
11.87%
345.93B
9.47%
312.30B
9.72%
325.44B
4.21%
368.30B
13.17%
492.38B
33.69%
455.83B
7.42%
526.09B
15.41%
633.33B
20.38%
729.92B
15.25%
other expenses
720.59B
-
1.00T
39.33%
795.22B
20.79%
705.13B
11.33%
707.38B
0.32%
908.87B
28.48%
1.43T
57.82%
1.41T
1.74%
588.87B
58.22%
-9.47B
101.61%
cost and expenses
1.55T
-
1.91T
22.85%
1.68T
12.09%
1.58T
5.99%
1.53T
3.01%
1.94T
26.70%
3.19T
64.74%
2.69T
15.74%
3.11T
15.61%
3.54T
13.80%
3.86T
9.20%
operating expenses
1.06T
-
1.39T
30.50%
1.14T
17.67%
1.02T
10.84%
1.03T
1.51%
1.28T
23.66%
2.10T
64.51%
1.69T
19.36%
2.00T
18.12%
2.29T
14.57%
1.78T
22.21%
interest expense
30.72B
-
32.88B
7.02%
31.93B
2.88%
23.25B
27.19%
31.93B
37.32%
48.16B
50.83%
165.01B
242.63%
248.63B
50.68%
166.61B
32.99%
169.70B
1.86%
219.85B
29.55%
ebitda
405.31B
-
148.39B
63.39%
349.85B
135.76%
389.38B
11.30%
431.26B
10.75%
376.38B
12.72%
687.90B
82.77%
1.17T
70.74%
1.05T
10.40%
1.21T
14.91%
1.13T
6.61%
operating income
139.27B
-
-129.25B
192.81%
130.83B
201.22%
155.87B
19.14%
241.79B
55.13%
204.97B
15.23%
100.41B
51.01%
509.27B
407.20%
460.84B
9.51%
490.50B
6.44%
401.22B
18.20%
depreciation and amortization
215.74B
-
260.95B
20.95%
197.38B
24.36%
222.79B
12.87%
182.13B
18.25%
272.45B
49.59%
583.65B
114.23%
559.67B
4.11%
583.15B
4.20%
664.40B
13.93%
728.00B
9.57%
total other income expenses net
1B
-
1.34B
33.70%
-3M
100.22%
-1.55B
51,433.33%
-32.20B
1,982.73%
-4.51B
85.99%
-23.99B
431.86%
76M
100.32%
-15.37B
20,319.74%
-8.63B
43.84%
-354.91B
4,012.47%
income before tax
158.85B
-
-145.44B
191.56%
120.54B
182.88%
143.35B
18.92%
217.21B
51.52%
94.90B
56.31%
-60.75B
164.02%
366.24B
702.82%
302.57B
17.38%
375.09B
23.97%
46.32B
87.65%
income tax expense
49.29B
-
-2.40B
104.88%
37.06B
1,642.20%
27.83B
24.90%
30.50B
9.57%
-14.12B
146.29%
-105.04B
644.04%
-9.94B
90.54%
72.41B
828.71%
58.05B
19.82%
-91.41B
257.46%
net income
106.66B
-
-145.78B
236.68%
80.17B
154.99%
114.94B
43.38%
186.89B
62.59%
109.13B
41.61%
44.24B
59.46%
376.00B
749.90%
230.06B
38.81%
317.02B
37.80%
144.07B
54.56%
weighted average shs out
789.47M
-
786.39M
0.39%
783.94M
0.31%
781.10M
0.36%
780.81M
0.04%
961.48M
23.14%
1.56B
61.96%
1.56B
0.31%
1.56B
0.10%
1.55B
0.75%
1.56B
0.81%
weighted average shs out dil
790.35M
-
786.40M
0.50%
788.18M
0.23%
785.89M
0.29%
786.71M
0.10%
966.90M
22.90%
1.57B
61.98%
1.57B
0.47%
1.58B
0.23%
1.57B
0.46%
1.58B
0.67%
eps
135.10
-
-185.37
237.21%
102.26
155.17%
147.15
43.90%
239.35
62.66%
113.50
52.58%
28.41
74.97%
240.72
747.31%
147.14
38.88%
204.29
38.84%
92.09
54.92%
epsdiluted
134.95
-
-185.37
237.36%
101.71
154.87%
146.26
43.80%
237.55
62.42%
112.86
52.49%
28.25
74.97%
238.96
745.88%
145.87
38.96%
201.94
38.44%
91.16
54.86%

All numbers in USD (except ratios and percentages)